XTalks

MAY 13, 2022

This highly sensitive method even works to detect package defects clogged by product formulation proteins or salts, explains Liss. The FDA’s CDRH (Center for Devices and Radiological Health) branch would own the filing in this case. The approaches have key differences in study design such as number of replicates required (i.e.

Packaging 98

Packaging Packaging Containment Production 98

The Pharma Data

JUNE 26, 2021

Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection. Moog Professor of Pulmonary Diseases in Medicine, and a professor of radiology – discovered that the virus they were using for experiments had picked up a mutation. Brody, MD, the Dorothy R.

Antibody 52

Antibody Vaccination Vaccine Research 52

Delveinsight

DECEMBER 10, 2020

Warding off Type 1 diabetes by aiming a T-cell protein. Scientists at the University of Utah School of Medicine have found a way to control that autoimmune response by aiming a protein that is vital for T-cell activation. The protein is known as OCA-B. UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

The Pharma Data

FEBRUARY 1, 2021

And just as it’s now widely recognized women experience heart disease differently than men, scientists are beginning to understand why the sexes experience illness differently in another vital organ – the brain. Her research suggests longer exposure to estradiol may offer some protection to the brain.

Hormones 40

Hormones Radiology Research Medicine 40

The Pharma Data

DECEMBER 23, 2020

scientists and public health experts, it was announced that there was a growing new strain of the SARS-CoV-2 virus that causes COVID-19. Not all scientists believe it is more contagious, although most are wondering how B.1.1.7 Of the 17 mutations, eight are in the gene that encodes the spike protein. The strain, B.1.1.7

Research 52

Research Protein Gene Vaccination 52

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. The University of Oxford/AstraZeneca partnership, in turn, is testing a viral-vectored coronavirus vaccine that again expresses the spike protein of SARS-CoV-2 virus.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92